The Aroon Indicator for BSFAF entered a downward trend on November 21, 2024. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 24 similar instances where the Aroon Indicator formed such a pattern. In of the 24 cases the stock moved lower. This puts the odds of a downward move at .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.814) is normal, around the industry mean (14.664). P/E Ratio (0.000) is within average values for comparable stocks, (87.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). BSFAF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (48.309) is also within normal values, averaging (260.687).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BSFAF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BSFAF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PSIFX | 45.43 | N/A | N/A |
PGIM Quant Solutions Large-Cap Index Z | |||
ITFEX | 10.35 | -0.04 | -0.38% |
Voya International High Div Low Vol S2 | |||
FMQRX | 15.11 | -0.07 | -0.46% |
Franklin Mutual Quest R6 | |||
SEKCX | 16.51 | -0.09 | -0.54% |
DWS Emerging Markets Equity C | |||
JGRJX | 38.40 | -0.23 | -0.60% |
JPMorgan Growth Advantage R2 |
A.I.dvisor indicates that over the last year, BSFAF has been closely correlated with BIESF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if BSFAF jumps, then BIESF could also see price increases.
Ticker / NAME | Correlation To BSFAF | 1D Price Change % | ||
---|---|---|---|---|
BSFAF | 100% | N/A | ||
BIESF - BSFAF | 82% Closely correlated | N/A | ||
SOLTF - BSFAF | 29% Poorly correlated | -2.01% | ||
YECO - BSFAF | 24% Poorly correlated | N/A | ||
APLM - BSFAF | 21% Poorly correlated | -8.87% | ||
CERO - BSFAF | 21% Poorly correlated | +19.80% | ||
More |